Clinical Trials Logo

Clinical Trial Summary

This study protocol examines a comparison between local and general anesthesia (Awake vs. Asleep Craniotomy) in the removal of brain tumors that are in areas of the brain that do not directly control bodily functions (non-eloquent gliomas).


Clinical Trial Description

This is a single-center, prospective randomized open or non-blinded end-point (PROBE) clinical trial. Patients will be selected by the neurosurgeon according to the inclusion and exclusion criteria. Patients who consent to randomization will have confirmed non-eloquent status confirmed by independent surgeon and will be randomized into 1 of 2 treatment groups utilizing a dynamic minimization approach. The experimental group with randomization of patients who will undergo awake craniotomy for both high and low grade gliomas in non-eloquent areas or a control group of patients who will have asleep craniotomy for both high and low grade gliomas in non-eloquent regions. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03621748
Study type Interventional
Source Mayo Clinic
Contact
Status Completed
Phase N/A
Start date June 1, 2019
Completion date May 21, 2023

See also
  Status Clinical Trial Phase
Recruiting NCT05556473 - F-Tryptophan PET/CT in Human Cancers Phase 1